STVN Stevanato Group S.p.A. Ordinary Shares

NYSE · US · Consumer Cyclical · Medical Instruments & Supplies · stevanatogroup.com

20.03USD-0.84%Mkt Cap: 5.51B $P/E: 36.07Today

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South A…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc. - Common Stock

$140.43BUSDP/E 44.8

EssilorLuxottica Société anonyme

$72.05BUSDP/E 27.0

BDX

Becton, Dickinson and Company Common Stock

$48.16BUSDP/E 30.5

MDLN

Medline Inc. - Class A common stock

$47.91BUSDP/E 44.5

RMD

ResMed Inc. Common Stock

Alcon Inc. Ordinary Shares

$30.82BUSDP/E 48.7

WST

West Pharmaceutical Services, Inc. Common Stock

$25.69BUSDP/E 46.8

DIM

Sartorius Stedim Biotech S.A.

$22.21BUSDP/E 69.8

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.16BUSDP/E 71.4

SOLV

Solventum Corporation Common Stock

$14.95BUSDP/E 10.7

BAX

Baxter International Inc. Common Stock

$12.14BUSD

COO

The Cooper Companies, Inc. - Common Stock

$10.82BUSDP/E 19.6

AVTR

Avantor, Inc. Common Stock

$10.38BUSD

COO

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

RGEN

Repligen Corporation - Common Stock

$10.25BUSDP/E 248.9

ALGN

Align Technology, Inc. - Common Stock

$10.21BUSDP/E 25.0

ATR

AptarGroup, Inc. Common Stock

$7.62BUSDP/E 21.6

Key Statistics

Company

Market Cap5.51B USD

Enterprise Value5.88B USD

Revenue (TTM)1.23B USD

Gross Profit343.88M USD

Net Income (TTM)139.84M USD

Revenue/Share4.49 USD

Last Price20.03 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees6.0K

CountryUS

SectorConsumer Cyclical

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)36.07

P/E (Forward)24.00

PEG1.45

EV/EBITDA19.69

EV/Revenue4.80

P/S4.50

P/B3.16

EPS (TTM)0.56

EPS (Forward)0.84

52W Range

12.8947% of range27.99

52W High27.99 USD

52W Low12.89 USD

Profitability

Gross Margin28.99%

Oper. Margin17.22%

EBITDA Margin24.39%

Profit Margin11.79%

ROE9.41%

ROA5.50%

Growth

Revenue Growth7.80%

Earnings Growth-26.50%

Cash Flow & Leverage

Operating CF286.08M USD

CapEx (TTM)275.03M USD

FCF Margin-8.55%

FCF Yield-1.90%

Net Debt366.16M USD

Net Debt/EBITDA1.23

Balance Sheet

Debt/Equity0.32

Current Ratio1.61

Quick Ratio1.08

Book Value/Sh6.39 USD

Cash/Share0.29 USD

Dividends

Fwd Div Rate0.06 USD

Trail. Div Rate0.00 USD

Div. Yield0.30%

5Y Avg Yield0.26%

Payout Ratio11.02%

Ex-Div DateJun 11, 2026

Pay DateJul 29, 2026

Analyst Consensus

Rating1.8 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)24.68 USD

Upside (mean)+23.2%

Target Range20.00 USD – 32.00 USD

20.00+23.2% to mean32.00

# Analysts12

Ownership

Shares Out.49.71M

Float49.04M

Insiders1.80%

Institutions97.66%

Short Interest

Short Ratio3.0d

Short % Float2.42%

Short % Out.0.43%

Shares Short1.19M

Short (prev mo.)1.03M

Technical

SMA 5021.07 (-4.9%)

SMA 20018.24 (+9.8%)

Beta0.75

S&P 52W Chg14.58%

Avg Vol (30d)316.69K

Avg Vol (10d)247.46K

Technical Indicators

RSI (14)40.2

MACD-0.1146

MACD Signal0.0760

MACD Hist.-0.1906

BB Upper22.63 USD

BB Middle21.19 USD

BB Lower19.75 USD

BB Width13.58%

ATR (14)0.8417 USD

Vol Ratio (20d)0.62x